Predictive value of serum high‐mobility group box 1 levels for checkpoint inhibitor pneumonitis
Sign Up to like & getrecommendations! Published in 2022 at "Respirology"
DOI: 10.1111/resp.14425
Abstract: Checkpoint inhibitor pneumonitis (CIP), caused by the anti‐programmed cell death‐1 (PD‐1)/programmed cell death ligand‐1 (PD‐L1) antibody, can be a fatal adverse event in cancer patients. However, no predictive biomarkers for CIP have been identified. Because… read more here.
Keywords: checkpoint inhibitor; mobility group; group box; high mobility ... See more keywords
Can radiomics combined with clinical data predict checkpoint inhibitor pneumonitis?
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.15_suppl.e14555
Abstract: e14555 Background: Immunotherapy (ImT) is increasingly utilized in patients with advanced non-small cell lung cancer (aNSCLC). Checkpoint-inhibitor pneumonitis (CIP) is an uncommon and potentially life-threatening adverse event (AE) associated with ImT. For patients with aNSCLC,… read more here.
Keywords: checkpoint inhibitor; inhibitor pneumonitis; cip; pre imt ... See more keywords